AF Innovations

Commercial Support

The commercial support of our industry colleagues, who are dedicated to educating health care professionals and to enhancing patient outcomes, helps make AF Innovations possible. With their assistance, AF Innovations is able to expand its educational reach and offer increasing educational opportunities to physicians and healthcare professionals worldwide.

The 3rd Annual AF Innovations: Live Cases from the Experts is dedicated to bridging knowledge gaps and fulfilling the unmet clinical needs of clinicians managing patients with Atrial Fibrillation.

Educational Support Inquires

To inquire about support of AF Innovations and/or any special sessions, including live cases or satellite symposia, please send an e-mail to: This e-mail address is being protected from spambots. You need JavaScript enabled to view it or call 856-438-5385

live af video case presentations

AF Innovations is grateful to the companies listed, who have supported the conference AF Innovations, for their ongoing support of quality, state-of-the-art, medical education.


Biosense Webster, Inc.
Biosense Webster is a worldwide leader in the science behind the diagnosis and treatment of cardiac arrhythmias with more than 1,300 professionals in 40 countries around the world. Biosense Webster, part of the Johnson & Johnson family of companies, has globally diverse employees dedicated to bringing the best healthcare options to our customers in the most ethical ways possible. Biosense Webster possesses an unparalleled commitment to scientific discovery that supports clinical trials and publishes scientific studies to advance the practice of electrophysiology and evaluate the safety and efficacy of new medical technology.


The Boehringer Ingelheim group of companies is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.


Boston Scientific
Our strategy is to lead global markets for less-invasive medical devices by developing and marketing innovative products, services and therapies that address unmet patient needs, provide superior clinical outcomes and demonstrate proven economic value.


CardioFocus, Inc.
CardioFocus is dedicated to the advancement of ablation treatments for cardiac disorders. Our laser ablation research is shedding new light on therapies for atrial fibrillation.

The CardioFocus Endoscopic Ablation System consists of the following items; Balloon Catheter, Deflectable Sheath Introducer, Endoscope and Integrated EAS Console.


CardioNet, Inc.
CardioNet has developed an integrated technology and service–Mobile Cardiac Outpatient Telemetry™ (MCOT™)—which enables heartbeat-by-heartbeat, ECG monitoring, analysis and response, at home or away, 24/7/365. CardioNet is focused on helping physicians diagnose and treat patients with arrhythmias. CardioNet offers physicians a powerful diagnostic and patient management tool to address these challenges.


Catheter Robotics, Inc.
Catheter Robotics Inc. is a medical device company founded in 2006. Our team has decades of experience developing medical devices that meet the needs of clinicians. We are focused on providing physicians comfort and safety while remaining committed to producing cost-effective, user friendly and technologically differentiated tools for use in percutaneous catheter procedures.

Keeping these commitments in mind, engineers, with the help of experienced physicians, developed Amigo™, a Remote Catheter System that incorporates the most modern technologies while remaining easy to learn and use.

Although the first application with Amigo will be in Electrophysiology, Amigo uses an open architecture design making it possible to use the system for additional catheter procedures. Future cardiac applications may include treatment of Abdominal Aortic Aneurysm, heart valve replacement or repair, Patent Foramen Ovale (PFO) repair and vascular applications.


Circa Scientific
CIRCA Scientific was founded in 2010 to innovate safe, accurate, and fast technologies for improved patient care. CIRCA’s S-CATH and the CIRCA Temperature Monitoring System address the problems associated with slow, single sensor, small surface area standard esophageal temperature probes and monitors, which are constructed with a single thermistor or thermocouple embedded inside a 3-5mm wide probe tip.


eCardio Diagnostics is the leading provider of remote cardiac monitoring products and services that improve the flexibility, speed and accuracy of arrhythmia diagnosis. Headquartered in Houston, Texas, eCardio has served thousands of physicians and patients suffering from heart rhythm disorders since 2004. eCardio is an important partner in the delivery of optimal patient care. eCardio offers an array of clinical services and leading-edge devices designed to simplify and streamline the process of arrhythmia monitoring. This allows physicians to make more precise diagnoses and enhances the follow-up and management of their patients.


LifeWatch is the nation’s leading ambulatory health monitoring services company. We offer a comprehensive platform of innovative patient technologies and services that help physicians detect and analyze symptoms before they become major health problems. LifeWatch Corp. enables physicians to establish stronger connections with at-risk patients and provide better guidance to patients. LifeWatch Corp. is a wholly owned subsidiary of LifeWatch AG, a leading healthcare technology and solutions provider listed on the Swiss Stock Exchange (LIFE).


Med A-Z
Med A-Z was formed by a team of information technology (IT) and clinical experts brought together to improve medical business processes. With 350 years of combined software development experience and 8 years of client feedback, we know what works. We strive to support our worldwide clients in expanding their best practices by building tools that advance these objectives directly into our products. At Med A-Z, it’s our goal to provide these services in a way that is totally secure, reliable and easy-to-use.


Medtronic, Inc.
At Medtronic, we're changing the face of chronic disease. By working closely with physicians around the world, we create therapies to help patients do things they never thought possible. Medtronic is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world. We're creating technologies that treat chronic disease in new ways so people can live better, longer.


nContact, Inc.
nContact was founded in June 2005 by our technology team, who hold over 100 patents in ablation technologies and helped develop the first surgical and catheter ablation tools for arrhythmia treatment.

nContact was started because catheter and surgical ablation companies had not solved two technical issues: the ability to consistently create visible linear lesions that could be connected into a comprehensive lesion pattern, and the ability to position and ablate on the posterior of the atrium under direct endoscopic visibility.


Philips Healthcare
Philips simplifies healthcare by focusing on the people in the care cycle – patients and care providers. Through combining human insights and clinical expertise, Philips aim to improve patient outcomes while lowering the burden on the healthcare system. Advanced healthcare solutions are a fundamental part of the portfolio for both healthcare professionals and consumers, to meet the needs of patients in hospitals and at home. Philips Healthcare employs approximately 34,000 people worldwide.


Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in healthcare, with 7 growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Through the acquisition of Genzyme, Sanofi has strongly reinforced its footprint in rare diseases.

sorin group

Sorin Group
SORIN GROUP is a global medical device company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders.

The company focuses on three major therapeutic areas, including; cardiopulmonary bypass, cardiac rhythm management (CRM), and heart valve repair and replacement.


St. Jude Medical, Inc.
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. St. Jude Medical is headquartered in St. Paul, Minnesota and has four major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation.

The St. Jude Medical product portfolio includes implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, pacemakers, electrophysiology catheters, mapping and visualization systems, vascular closure devices, structural heart products, spinal cord stimulation and deep brain stimulation devices.